van Nguyen, MD
Cardiovascular Disease · Safety Harbor, FLNPI 1205898236
Payments from drug & device makers
Across 592 payments — averaging $1090.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$393K
- Boehringer Ingelheim International GmbH$108K
- Boehringer Ingelheim Pharma GmbH & Co.kg$64K
- Merck$41K
- Alnylam Pharmaceuticals Inc.$23K
- Amgen$15K
- plus $2K from 19 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 28 | $392,600 |
| Boehringer Ingelheim International GmbH | 283 | $108,200 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 25 | $64,044 |
| Merck | 15 | $40,974 |
| Alnylam Pharmaceuticals Inc. | 80 | $22,893 |
| Amgen | 48 | $14,783 |
| Pfizer | 30 | $453 |
| AstraZeneca | 14 | $334 |
| Amarin Pharma, Inc. | 14 | $217 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $216 |
| E.r. Squibb & Sons, L.L.C. | 15 | $206 |
| Boehringer Ingelheim | 4 | $170 |
| Sanofi-aventis U.S. LLC | 4 | $72 |
| Johnson & Johnson | 5 | $66 |
| Esperion Therapeutics, Inc. | 4 | $62 |
| Novo Nordisk | 2 | $45 |
| Actelion Pharmaceuticals US, Inc. | 2 | $43 |
| Nuwellis, Inc. | 1 | $36 |
| Medtronic | 1 | $32 |
| Lexicon Pharmaceuticals, Inc. | 2 | $29 |
| Kestra Medical Technology Services, Inc. | 1 | $26 |
| Chiesi USA, Inc. | 2 | $25 |
| Boston Scientific | 1 | $19 |
| Biosense Webster, Inc. | 1 | $18 |
| Bayer | 1 | $17 |
How this compares
$645,581 in reported general payments places this provider in the 95th percentile of 1,740 cardiovascular disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Safety Harbor
- Michael KorenGainesville$31M
- Seth BaumBoca Raton$11.1M
- Alexis GutierrezHialeah$8M
- Eric SpivackAventura$7.1M
- William OneillNaples$4.6M
- Rafik AbadierInverness$4.4M
- Alvaro MurciaPembroke Pines$4M
- David HotchkissPort Charlotte$4M
- Ferris GeorgeSt Augustine$3.8M
- Duccio BaldariWellington$3.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.